Beijing Tiantan Biological Products (SHSE:600161) Other Income (Minority Interest) : ¥-418 Mil (TTM As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. Beijing Tiantan Biological Products's Other Income (Minority Interest) for the three months ended in Mar. 2024 was ¥-115 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-418 Mil.

Beijing Tiantan Biological Products Other Income (Minority Interest) Historical Data

The historical data trend for Beijing Tiantan Biological Products's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Other Income (Minority Interest) Chart

Beijing Tiantan Biological Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Minority Interest)

Get a 7-Day Free Trial

-283.16

-304.07

-308.80

-323.76

-399.57

Beijing Tiantan Biological Products Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Minority Interest)	Get a 7-Day Free Trial															-97.07	-110.33	-112.81	-79.35	-115.45

Beijing Tiantan Biological Products Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-418 Mil.

Beijing Tiantan Biological Products (SHSE:600161) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Beijing Tiantan Biological Products (SHSE:600161) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Other Income (Minority Interest)

Traded in Other Exchanges

N/A

Address

No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024

Website

http://www.tiantanbio.com

Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.

Executives

Wang Jian Ming	Supervisors
Liu Ya Na	Directors, senior managers
Fu Dao Xing	Directors, senior managers
He Yan Lin	Directors, senior managers
Hu Li Gang	Director
Ci Xiang	senior management
Yang Hui Chuan	Director
Zhang Yi	senior management
Wu Zhen Shan	senior management

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines